Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo

Published 2016 View Full Article

Authors

Keywords

oxaliplatin resistance, copper transporter hCtr1, transferrin transporter TfR1, Desferal, specificity protein 1 Sp1

Journal

Oncotarget

Volume 7, Issue 31, Pages -

Publisher

Impact Journals, LLC

Online

2016-07-01

DOI

10.18632/oncotarget.10336

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now